LCM
CRL icon

Logan Capital Management’s Charles River Laboratories CRL Stock Holding History

Logan Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
+7,584
New +$1.35M 0.06% 183
2026
Q1 		– Sell
-10,975
Closed -$2.03M – 327
2025
Q4 		$2.19M Sell
10,975
-2,042
-16% -$370K 0.09% 164
2025
Q3 		$2.04M Buy
13,017
+1,930
+17% +$307K 0.09% 167
2025
Q2 		$1.68M Sell
11,087
-487
-4% -$64.9K 0.08% 172
2025
Q1 		$1.74M Sell
11,574
-10,482
-48% -$1.76M 0.08% 179
2024
Q4 		$4.07M Sell
22,056
-1,674
-7% -$322K 0.17% 127
2024
Q3 		$4.67M Sell
23,730
-275
-1% -$57.1K 0.19% 120
2024
Q2 		$4.96M Sell
24,005
-353
-1% -$80K 0.21% 116
2024
Q1 		$6.6M Buy
24,358
+3,201
+15% +$764K 0.28% 100
2023
Q4 		$5M Sell
21,157
-2,400
-10% -$472K 0.23% 112
2023
Q3 		$4.62M Buy
23,557
+2,832
+14% +$581K 0.23% 112
2023
Q2 		$4.36M Sell
20,725
-2,488
-11% -$495K 0.21% 120
2023
Q1 		$4.68M Buy
23,213
+889
+4% +$201K 0.23% 115
2022
Q4 		$4.86M Sell
22,324
-132
-0.6% -$28.8K 0.25% 104
2022
Q3 		$4.42M Buy
22,456
+1,866
+9% +$403K 0.26% 97
2022
Q2 		$4.41M Sell
20,590
-1,146
-5% -$280K 0.25% 104
2022
Q1 		$6.17M Buy
21,736
+416
+2% +$128K 0.3% 96
2021
Q4 		$8.03M Buy
21,320
+512
+2% +$199K 0.35% 86
2021
Q3 		$8.59M Sell
20,808
-611
-3% -$254K 0.4% 77
2021
Q2 		$7.92M Buy
21,419
+1,689
+9% +$564K 0.37% 81
2021
Q1 		$5.72M Buy
19,730
+1,468
+8% +$408K 0.29% 95
2020
Q4 		$4.56M Buy
+18,262
New +$4.35M 0.23% 109

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Logan Capital Management's CRL Position: Q2 2026 in Review

Logan Capital Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 7,584 shares worth $1.72M. The stake represents 0.06% of the portfolio and ranks #183 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in CRL as recently as Q4 2025.

Logan Capital Management first reported a position in CRL in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.59M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Logan Capital Management held 7,584 shares of Charles River Laboratories worth $1.72M as of Q2 2026.
  • Charles River Laboratories was a new Logan Capital Management position in Q2 2026.
  • Charles River Laboratories made up 0.06% of Logan Capital Management's portfolio in Q2 2026, its #183 holding.
  • Logan Capital Management first reported a position in Charles River Laboratories in Q4 2020 and has held it in 22 quarters since.
  • Logan Capital Management's Charles River Laboratories position peaked at $8.59M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.